Correlation of iron exchange between the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one(L1) and transferrin and possible antianaemic effects of L1 in rheumatoid arthritis. 1990

G Vreugdenhil, and A J Swaak, and C de Jeu-Jaspers, and H G van Eijk

UI MeSH Term Description Entries
D007502 Iron Chelating Agents Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. Iron Chelates,Agents, Iron Chelating,Chelates, Iron,Chelating Agents, Iron
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077543 Deferiprone A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA. 1,2-Dimethyl-3-hydroxy-4-pyridinone,1,2-Dimethyl-3-hydroxypyrid-4-one,1,2-Dimethyl-3-hydroxypyridin-4-one,3-Hydroxy-1,2-dimethyl-4-pyridinone,DMOHPO,Ferriprox,HDMPP,1,2 Dimethyl 3 hydroxy 4 pyridinone,1,2 Dimethyl 3 hydroxypyrid 4 one,1,2 Dimethyl 3 hydroxypyridin 4 one,3 Hydroxy 1,2 dimethyl 4 pyridinone
D000740 Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. Anemias
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

G Vreugdenhil, and A J Swaak, and C de Jeu-Jaspers, and H G van Eijk
August 1992, Blood,
G Vreugdenhil, and A J Swaak, and C de Jeu-Jaspers, and H G van Eijk
January 1990, Annals of the New York Academy of Sciences,
G Vreugdenhil, and A J Swaak, and C de Jeu-Jaspers, and H G van Eijk
October 1990, British journal of haematology,
G Vreugdenhil, and A J Swaak, and C de Jeu-Jaspers, and H G van Eijk
September 1990, Clinical pharmacology and therapeutics,
G Vreugdenhil, and A J Swaak, and C de Jeu-Jaspers, and H G van Eijk
October 1990, British journal of haematology,
G Vreugdenhil, and A J Swaak, and C de Jeu-Jaspers, and H G van Eijk
November 1991, Nederlands tijdschrift voor geneeskunde,
G Vreugdenhil, and A J Swaak, and C de Jeu-Jaspers, and H G van Eijk
January 1993, Bone marrow transplantation,
G Vreugdenhil, and A J Swaak, and C de Jeu-Jaspers, and H G van Eijk
December 1987, British medical journal (Clinical research ed.),
G Vreugdenhil, and A J Swaak, and C de Jeu-Jaspers, and H G van Eijk
April 1990, Seminars in hematology,
G Vreugdenhil, and A J Swaak, and C de Jeu-Jaspers, and H G van Eijk
April 1990, Veterinary and human toxicology,
Copied contents to your clipboard!